3,123
Views
21
CrossRef citations to date
0
Altmetric
Article

Preparation, characterization and in vitro evaluation of PEGylated nanoliposomal containing etoposide on lung cancer

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 3222-3230 | Received 16 May 2019, Accepted 14 Jul 2019, Published online: 02 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shen Hui Min, Wang Lei, Chen Jia Jun, Zhang Shao Yan, Yang Xu Guang, Zhang Tong, Zheng Pei Yong, Lu Zhen Hui & Huang Xing. (2023) Design strategy and research progress of multifunctional nanoparticles in lung cancer therapy. Expert Opinion on Investigational Drugs 32:8, pages 723-739.
Read now
Douweh Leyla Gbian & Abdelwahab Omri. (2021) Current and novel therapeutic strategies for the management of cystic fibrosis. Expert Opinion on Drug Delivery 18:5, pages 535-552.
Read now

Articles from other publishers (19)

Michael R. Arul, Ibtihal Alahmadi, Daylin Gamiotea Turro, Aditya Ruikar, Sama Abdulmalik, Justin T. Williams, Basavaraju G. Sanganahalli, Bruce T. Liang, Rajkumar Verma & Sangamesh G. Kumbar. (2023) Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy. Biomaterials Science 11:24, pages 7856-7866.
Crossref
Pavani Chowdary, Ananya Padmakumar & Aravind Kumar Rengan. (2023) Exploring the potential of transethosomes in therapeutic delivery: A comprehensive review. MedComm – Biomaterials and Applications 2:4.
Crossref
Sonia Fathi-karkan, Rabia Arshad, Abbas Rahdar, Aghdas Ramezani, Razieh Behzadmehr, Suresh Ghotekar & Sadanand Pandey. (2023) Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review. European Journal of Medicinal Chemistry 259, pages 115676.
Crossref
Prathapan Abeesh, Phillipe Bouvet & Chandrasekaran Guruvayoorappan. (2023) AS1411 aptamer tagged PEGylated liposomes as a smart nanocarrier for tumor-specific delivery of Withaferin A for mitigating pulmonary metastasis. Biomaterials Advances 154, pages 213661.
Crossref
Bhupendra G. PrajapatiHimanshu PaliwalMayuree Patel. (2023) Fabrication and Evaluation of Polymeric Nanoparticles of Acitretin for the Solubility Enhancement. Research Journal of Pharmacy and Technology, pages 2655-2660.
Crossref
Zhenxian Li, Haimei Zhu, Hao Liu, Dayue Liu, Jianhe Liu, Jiazheng Jiang, Yi Zhang, Zhang Qin, Yijia Xu, Yuan Peng, Bin Liu & Yun Long. (2023) Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy. Journal of Nanobiotechnology 21:1.
Crossref
Zhihua Wang, Ye Wang, Hailiang Li, Yuanxiang Lan, Zhong Zeng, Jian Yao, Mei Li & Hechun Xia. (2023) Fabrication of Etoposide-loaded superparamagnetic iron oxide nanoparticles (SPIONs) induced apoptosis in glioma cancer cells. Process Biochemistry 128, pages 126-136.
Crossref
Nosrat O. Mahmoodi, Seyed Mohammadreza Alavi & Asieh Yahyazadeh. (2022) Formulation and therapeutic efficacy of PEG-liposomes of sorafenib for the production of NL-PEG-SOR FUM and NL-PEG-SOR TOS. Research on Chemical Intermediates 48:9, pages 3915-3935.
Crossref
Douweh Leyla Gbian & Abdelwahab Omri. (2022) Lipid-Based Drug Delivery Systems for Diseases Managements. Biomedicines 10:9, pages 2137.
Crossref
Balsam Qubais Saeed, Mutasem Rawas Qalaji, Noor Akbar, Ruqaiyyah Siddiqui, Cagliani Roberta, Shaista Manzoor, Jibran Sualeh Muhammad, Ahmed Omar Adrees, Rula Al-Shahrabi & Naveed Ahmed Khan. (2022) Evaluation of nanoparticles with 5-fluorouracil and chloroquine on Acanthamoeba castellanii activity. Molecular and Biochemical Parasitology 250, pages 111492.
Crossref
Asawaree Anand Hable, Swati Changdeo Jagdale & Aniruddha Rajaram Chabukswar. (2022) Selection of Optimum Method for Nanoparticles in Lung Cancer Therapeutics. Biosciences Biotechnology Research Asia 19:2, pages 321-331.
Crossref
Mariza Aires‐Fernandes, Josimar O. Eloy, Francesca Damiani Victorelli, Paula Scanavez Ferreira, Andressa Maria Pironi & Marlus Chorilli. (2021) Reversed‐phase high‐performance liquid chromatography: A fast and efficient analytical method to quantify docetaxel‐loaded pegylated liposomes in release study. Journal of Separation Science 44:21, pages 3986-3995.
Crossref
Mona M. Agwa, Marwa M. Abu-Serie, Doaa A. Abdelmonsif, Nermine Moussa, Hassan Elsayed, Sherine N. Khattab & Sally Sabra. (2021) Vitamin D3/phospholipid complex decorated caseinate nanomicelles for targeted delivery of synergistic combination therapy in breast cancer. International Journal of Pharmaceutics 607, pages 120965.
Crossref
Junli Zhang, Kaiyan Wei, Jinjin Shi, Yifan Zhu, Mengting Guan, Xudong Fu & Zhenzhong Zhang. (2021) Biomimetic Nanoscale Erythrocyte Delivery System for Enhancing Chemotherapy via Overcoming Biological Barriers. ACS Biomaterials Science & Engineering 7:4, pages 1496-1505.
Crossref
Hend Mohamed Abdel‐Bar, Adam A. Walters, Julie Tzu‐Wen Wang & Khuloud T. Al‐Jamal. (2021) Combinatory Delivery of Etoposide and siCD47 in a Lipid Polymer Hybrid Delays Lung Tumor Growth in an Experimental Melanoma Lung Metastatic Model. Advanced Healthcare Materials 10:7.
Crossref
Martina Di Francesco, Christian Celia, Maria Chiara Cristiano, Nicola d’Avanzo, Barbara Ruozi, Constantin Mircioiu, Donato Cosco, Luisa Di Marzio & Massimo Fresta. (2021) Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer. ACS Omega 6:4, pages 2973-2989.
Crossref
Silvana Alfei, Barbara Marengo & Cinzia Domenicotti. (2020) Polyester-Based Dendrimer Nanoparticles Combined with Etoposide Have an Improved Cytotoxic and Pro-Oxidant Effect on Human Neuroblastoma Cells. Antioxidants 9:1, pages 50.
Crossref
Hira Choudhury, Rahul Maheshwari, Manisha Pandey, Muktika Tekade, Bapi Gorain & Rakesh Kumar Tekade. (2020) Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug ‘Etoposide’. Materials Science and Engineering: C 106, pages 110275.
Crossref
Azam Akbari, Azim Akbarzadeh, Morteza Rafiee TehraniReza Ahangari Cohan, Mohsen ChianiMohammad Reza Mehrabi. (2019) Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells. Advanced Pharmaceutical Bulletin 10:1, pages 39-45.
Crossref